b
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
Introduction：Rosuvastatin calcium is an anti hyperlipidemic drug, which belongs to HMG CoA reductase inhibitor. It was successfully developed by AstraZeneca in the UK. It is suitable for the treatment of a variety of lipid abnormalities, including hypercholesterolemia, mixed lipid abnormalities and simple hypertriglyceridemia. Rosuvastatin calcium is the statins with the strongest lipid-lowering effect and the most comprehensive lipid-lowering effect among the listed lipid-lowering drugs. It has better effects on reducing low-density lipoprotein cholesterol and increasing high-density lipoprotein than atorvastatin, which is recognized as the most effective in the world, and has better tolerance, lower side effects and unique pharmacokinetic characteristics.
CAS：147098-20-2
Molecular formula：C22H30CaFN3O6S
Molecular weight：523.63
Structure：
Uses：Used as hypolipidemic drugs
Manufacturing
